BootstrapLabs portfolio company, Mendel, is codifying COVID-19

Mendel, a BootstrapLabs portfolio company, has announced that they have assembled a task force to address COVID-19 using applied artificial intelligence. Please see this announcement from Mendel Founder & CEO Karim Galil:

Hello, World!

Mendel has ramped up it’s working force and assembled a 50+ special task force of AI scientists, physicians, and clinical experts to address COVID-19 with clinical artificial intelligence—because it’s basically the one thing we know how to do to save lives.

The goal is to absorb the learnings in the literature and cross-reference with the EMR data of COVID-19 +ve patients to answer key questions and corroborate findings faster with greater accuracy than humans. We are using novel clinical AI models, which we’ve been quietly building the last 2 years, to:

1- Parse and analyze 30,000 scholarly articles related to CoV. Mendel AI is trained to understand the clinical context and make valid inferences. For example, a “transmission” query returns something like “no intrauterine infection reported”.

2- Deidentify and analyze medical records of COVID-19 patients. Mendel AI extracts temporal relations, or simply put: the sequence of clinical events, by parsing a patient MR without risking privacy. This approach should help predict the course of SARS- CoV, and the outcome of different drugs and treatment approaches.

The scientific and clinical community can use these powerful tools and leverage our AI technologies for free, in a few days, via a web application.

We are currently looking for partners to sustain this initiative and spread its impact. Please ping me if you think you can help or if you just need access.

Believe!

Karim Galil

BootstrapLabs is proud to be supporting Karim and his team with this important effort. If you can help, or need access to Mendel’s soon to be released web application we will be happy to provide an introduction. Please contact us at info@draftbootstraplabs.wp.bootstraplabs.com.